Evidence map›Paper›PMID 29465685›Full record

ArticleSexually transmitted diseases2018

Ciprofloxacin May be Efficacious in Treating Wild-Type Gyrase A Genotype Neisseria gonorrhoeae Infections.

Lao-Tzu Allan-Blitz, Peera Hemarajata, Romney M Humphries, Mabel Kimble, Sam Elias, Jeffrey D Klausner

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Sexually transmitted diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Resistance-Guided Treatment of Gonorrhea: A Prospective Clinical Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Trial
  2. Evaluation of the Allplex NG & DR assay for molecular prediction of ciprofloxacin and azithromycin resistance in Neisseria gonorrhoeae.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  3. Article
  4. Point-by-Point Progress: Gonorrhea Point of Care Tests.Expert review of molecular diagnostics · 2020
    Article
  5. Article
  6. Article
  7. Antimicrobial Susceptibility ofAntibiotics (Basel, Switzerland) · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lao-Tzu Allan-BlitzDavid Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA. lallanblitz@mednet.ucla.edu Department of Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA Division of Infectious Diseases, Department of Medicine, University of California, Los Angeles, Los Angeles, CA Arthur Ashe Student Health & Wellness Center, University of California, Los Angeles, Los Angeles, CA Division of Infectious Diseases, Department of Medicine, University of California, Los Angeles, Los Angeles, CA Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles, Los Angeles, CA.
Peera Hemarajata
Romney M Humphries
Mabel Kimble
Sam Elias
Jeffrey D Klausner

Funding

Reducing excess broad-spectrum antibiotic use in gonorrheaR21AI117256 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KLAUSNER, JEFFREY DAVID · 2016 to 2017
$424k
Controlling Drug Resistant Gonorrhea with Real-Time PCR Susceptibility TestingR21AI109005 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KLAUSNER, JEFFREY DAVID · 2014 to 2015
$362k
NIAID NIH HHS R21 AI109005NIAID NIH HHS R21 AI117256
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsCiprofloxacinDNA GyraseDrug Resistance, BacterialGenotypeGonorrheaHumansMedical RecordsMicrobial Sensitivity TestsNeisseria gonorrhoeaeRetrospective StudiesAnti-Bacterial AgentsCiprofloxacinDNA Gyrase

Identifiers

PMID29465685
PMCPMC5847432

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.